FdaApplication
ANDA 219529
Identifiers
- fda_app_no: ANDA219529
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2026-05-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | EQ 0.25MG BASE/ML | INJECTABLE;INJECTION |
1 product